
==== Front
ACS OmegaACS OmegaaoacsodfACS Omega2470-1343American Chemical Society 3145895310.1021/acsomega.8b01179ArticleCopper-Catalyzed Diversity-Oriented
Synthesis (DOS) of 4-Amino-2H-chromen-2-imines:
Application of Kemp Elimination
toward O-Heterocycles Chen Zhiyuan *†‡Han Cuifen ‡Fan Congbin †Liu Gang †Pu Shouzhi *†† Jiangxi
Key Laboratory of Organic Chemistry, Jiangxi
Science and Technology Normal University, 605 Fenglin Road, Nanchang, Jiangxi 330013, P. R. China‡ Key
Laboratory of Functional Small Organic Molecules, Ministry of Education,
and College of Chemistry & Chemical Engineering, Jiangxi Normal University, 99 Ziyang Road, Nanchang, Jiangxi 330022, P. R. China* E-mail: zchen@jxnu.edu.cn (Z.C.).* E-mail: pushouzhi@tsinghua.org.cn (S.P.).23 07 2018 31 07 2018 3 7 8160 8168 30 05 2018 05 07 2018 Copyright © 2018 American Chemical
Society2018American Chemical
SocietyThis is an open access article published under an ACS AuthorChoice License, which permits copying and redistribution of the article or any adaptations for non-commercial purposes.

We report herein a copper-catalyzed
sequential multicomponent reaction
of benzo[d]isoxazoles with terminal alkynes and sulfonyl
azides, which produced divergent 4-amino-2H-chromen-2-imines
with excellent chemical selectivity. The reaction tolerated a broad
range of functional groups, and released only N2 as the
sole byproduct. The sulfonyl imino group could be removed to give
biologically active free 4-amino-2H-chromenone in
good yield.

document-id-old-9ao8b01179document-id-new-14ao-2018-01179yccc-price
==== Body
Introduction
Chromenone motifs are
valuable category of O-containing heterocycles
that widely exist in nature, pharmaceutical agents, and synthetic
intermediates.1 Among the most significant
subfamilies of chromenones, the amino substitution on the pyranone
ring have attracted much attention recently, due to their potent effects
in medicinal applications or clinical therapeutic effects. A particular
example is 3-aminochromen-4-one, which has been reported to be cytotoxic
active, and has the ability to inhibit cyclic AMP phosphodiesterase.2 In addition, a series of 2- or 3-amino-substituted
chromones have been identified to possess antiproliferative activities,
antiviral and enzymatic inhibition,3 and
antirheumatic activities.4 The 4-amino-substituted
chromones have been recently recognized as a useful substrate to prepare
bioactive chromeno[4,3-b]pyrrol-4(1H)-one derivatives.5

To date, there
are many methods including step-wise synthesis,6 pyranone ring cyclizations,7 and conjugate addition reactions,8 which
have been reported to effectively construct the chromone core
structures. Although these approaches have been used frequently for
the synthesis of chromone family members, they are not applicable
for the synthesis of 2-imino-substituted or 2-amino-substituted chromenones.
Recently, some new protocols have been successfully developed to prepare
2H-chromen-2-imines. For example, in 2011, Liu and
Wang’s group reported a microwave-assisted two-step synthesis
of 2-iminocoumarin-3-carboxamide derivatives.9 Later, Punniyamurthy developed a copper(I)-catalyzed one-pot synthesis
of iminocoumarin aryl methyl ethers starting from ynal, phenol, and
sulfonyl azide.10 Li and co-workers described
a straightforward path to the 2-aryliminochromene skeleton via a cascade
three-component coupling reaction of arynes, N,S-keteneacetals, and dimethylformamide (DMF).11 It should be noted that although these protocols
have been frequently utilized in the synthesis of 2- or 3-amino-substituted
coumarin derivatives, less attention has been focused on 4-amino-2H-chromen-2-imines, which have found noticeable applications
in medicinal sciences and biological studies.12

We were interested in developing novel domino reactions to
construct
combinatorial natural products like small organic molecules for the
use in different biological assays.13 A
tandem-type cyclization that employs the first-row transition-metals
is of particular interest because this would obviate the need for
toxic and expensive heavy metal species. Our access to the amination
of chromenone derivatives was inspired by the Cu-catalyzed regioselective
Huisgen azide–alkyne cycloaddition (CuAAC) reaction of azides
and terminal alkynes.14 The key to the
success of CuAAC is the in situ generation of a reactive ketenimine
intermediate, which could be chemo- and regioselectively transformed
into various heterocyclic molecules as disclosed by the groups of
Chang and Wang,15 and recently among others.16 Copper-catalyzed tandem cyclization of ketenimine
intermediates with different dipole nucleophile–electrophile
building blocks such as 2-hydroxylacetophenones and 2-hydroxyphenylpropiolates
has so far been explored to construct 2-iminocoumarins or similar
fused O-heterocycles.17 Recently, the Zhang
and Yi’s group reported an expedient synthesis of 4-amino-2H-chromen-2-imines by the combination of copper-catalyzed
CuAAC reaction with 2-hydroxybenzonitriles.18 The development of novel dipole nucleophile–electrophile
building blocks for difunctionalization of the intermediate species
can be expected, thus expanding the synthetic applications of useful
cyclic molecules in step-economic domino reactions. Motivated by the
pioneering works mentioned above, we herein present a novel Cu-catalyzed
three-component cycloaddition reaction of benzo[d]isoxazole 1 with the in situ generated sulfonylketenimines
from Huisgen azide–alkyne adducts, to produce functionalized
4-amino-4H-chromen-2-one imines 4 in
good yields with excellent chemo- and regioselectivity.

Benzo[d]isoxazoles are readily available and stable
substances, they have been recently employed to prepare various aza-heterocycles
based on the nucleophilicity of the nitrogen atom in the molecule.19 The Kemp elimination is a well-studied reaction
in which a catalytic base abstracts a proton from the benzo[d]isoxazole ring, and thus results in ring-opening to form
the cyanophenol product (Scheme 1).20,21 Ever since its discovery, this
protocol has been established as an important tool to develop conceptually
innovative organocatalysis.22 We envisioned
that this anionic cyanophenol species could react with the highly
reactive ketenimine species in suitable catalytic conditions through
[4 + 2] cycloaddition process, thus giving the targeted 2-aminochromenone
imines in a one-pot procedure. Interestingly, to our knowledge, there
are currently very few reports to prepare O-heterocycles based on
Kemp elimination process.

Scheme 1 Kemp Elimination Reaction and Its Application
in the Synthesis of
O-Containing Heterocycles
Results and Discussion
We first screened the reaction
conditions in the copper-catalyzed
three-component cyclization of benzo[d]isoxazole 1a with tosyl azide 2a and terminal alkyne 3a (Table 1). We supposed that the addition of base should be crucial for both
of the desired Kemp elimination and triazole decomposition in this
reaction. Indeed, when triethylamine (TEA) was added, the expected
4-amino-2H-chromen-2-imine 4a was identified,
albeit in very low yield at room temperature (entry 1). A brief screening
of the copper catalyst, including Cu(I) and Cu(II) salts, indicated
that CuBr gave a slightly improved yield of 21% (entries 2–5).
Typically, the undesired Huisgen adduct 4a′ (10–15%),14,23 and the remaining substrate 1a (>61%) accounted
for
the mass balance. The unusual slow conversion of this reaction was
ascribed to the fact that the basic azaheterocycle 1a can potentially deactivate the metal catalyst via coordination.
In addition, the slow Kemp elimination of 1a and the
poor solubility of product 4a should be taken into account.
With these considerations in mind, we next raised the reaction temperature
to a reflux condition of 80 °C in dichloroethane (DCE). Gratifyingly,
a smooth reaction was observed to proceed for 4 h, the desired product 4a was isolated in 74% yield (entry 6). A comparative result
was observed when diisopropylethylamine (DIPEA) was employed (entry
7), whereas, the addition of other bases like K2CO3, pyridine, and 1,4-diazabicyclo[2.2.2]octane (DABCO) all
failed to achieve any improvement, and worse yet the triazole 4a′ remained dominant in these cases (entries 8–10).
The aims to reduce the loading of the copper catalyst and base gave
no superior results, thus, 10 mol % of CuBr and 3.0 equiv of TEA were
chosen as the optimal conditions for this three-component transformation
(entries 11 and 12). Solvent screening indicated that modest yield
was obtained in CHCl3, and no superior result was observed
in 1,4-dioxane or toluene. It should be noted that complex results
were observed in strong polar solvents like tetrahydrofuran (THF),
DMF, and dimethyl sulfoxide (DMSO) (entries 13–18). Notably,
a significant improvement in product formation was achieved when a
mixture of organochlorine solvent was employed (entries 19–21).
The expected product 4a could be isolated in 89% yield
in 0.1 M of DCE/dichloromethane (DCM) (1:1, v/v) system (entry 19).

Table 1 Optimization of the Conditionsa
entry	cat. (x)	base (equiv)	solvent	T/°C, t/h	yield (%)	
1	CuI (10)	TEA (3)	DCE	25, 12	19	
2	CuBr (10)	TEA (3)	DCE	25, 12	21	
3	CuCl (10)	TEA (3)	DCE	25, 12	13	
4	CuCN (10)	TEA (3)	DCE	25, 24	5	
5	Cu(OTf)2 (10)	TEA (3)	DCE	25, 12	17	
6	CuBr (10)	TEA (3)	DCE	80, 4	74	
7	CuBr (10)	DIPEA (3)	DCE	80, 4	69	
8	CuBr (10)	K2CO3 (3)	DCE	80, 4	10	
9	CuBr (10)	Py (3)	DCE	80, 4	0	
10	CuBr (10)	DABCO (3)	DCE	80, 4	5	
11	CuBr (10)	TEA (2)	DCE	80, 4	64	
12	CuBr (5)	TEA (3)	DCE	80, 4	43	
13	CuBr (10)	TEA (3)	CHCl3	80, 4	50	
14	CuBr (10)	TEA (3)	THF	80, 4	0	
15	CuBr (10)	TEA (3)	1,4-dioxane	80, 4	22	
16	CuBr (10)	TEA (3)	toluene	80, 4	22	
17	CuBr (10)	TEA (3)	DMF	80, 4	trace	
18	CuBr (10)	TEA (3)	DMSO	80, 4	0	
19	CuBr (10)	TEA (3)	DCE/DCM (1:1)	80, 4	89	
20	CuBr (10)	TEA (3)	DCE/CHCl3 (1:1)	80, 4	80	
21	CuBr (10)	TEA (3)	DCE/DCM (1:1) (0.5 M)	80, 4	84b	
a Reaction conditions:
benzo[d]isoxazole 1a (0.24 mmol), azide 2a (0.40 mmol), and alkyne 3a (0.20 mmol) in
2.0 mL of
solvent under N2. Gas chromatography yield was estimated
with naphthalene as an internal standard. Isolated yield in parentheses.

b Solvent = 1.0 mL. DABCO = 1,4-diazabicyclo[2.2.2]octane.

The reaction scope for this
convenient preparation of 4-amino-2H-chromen-2-imines 4 was next studied as presented
in Table 2. Employing
benzo[d]isoxazole 1a and tosyl azide 2a as starting materials, the reactivity of various terminal
alkynes 3 was evaluated. The aromatic alkynes that bear
electron-donating functionalities (OMe, nBu) at the
para position of the phenyl ring participated in this three-component
reaction smoothly, affording the corresponding products 3b and 3d in 68 and 96% yields, respectively. The structure
of compound 4d was verified unambiguously through X-ray
crystallography analysis.24 The synthetically
useful halo-substituents such as fluoro (4e) and bromo
(4f) groups were tolerated, which indicate that the further
elaborations based on these synthetic handles can be applicable. The
ester moiety attached on the phenyl ring of alkyne underwent the reaction
smoothly to give product 4g in moderate yield. In addition
to these aryl terminal alkynes, the 3-thienyl heterocycle could also
participate in this reaction, thus furnishing the bis-heterocyclic
compound 4h in 71% yield. A sluggish result of aliphatic
alkyne 3i with 1a and 2a was
observed under the standard conditions. Fortunately, in modified reaction
conditions, we found that when mixing tosyl azide 2a with
oct-1-yne 3i in anhydrous DCE firstly under the catalysis
of CuBr at room temperature, followed by the addition of benzo[d]isoxazole 1a and TEA, the product 4i could be successfully isolated at 80 °C in 62% yield. By utilizing
this optimal procedure, the structurally strained cycloalkyl group
could also be compatible, the reaction of 1a and 2a with ethynylcyclopropane afforded the expected product 4j in 65% yield.

Table 2 Substrate Scope for
the Synthesis
of 4a
a Reaction conditions: 1a (0.24 mmol), 2a (0.40 mmol), terminal alkyne 3 (0.20 mmol) in 2.0 mL of DCE at 80 °C. Isolated yield
based on 3.

b Compound 2a and alkyl
alkyne 3 firstly reacted in DCE under the catalysis of
CuBr for 1 h at room temperature, followed by the addition of substrate 1a and TEA, the mixture was then stirred at 80 °C for
an additional 4 h.

To further
explore the synthetic utility of this diversity-oriented
method for the synthesis of more complex O-heterocyclic imines 5, we employed a variety of functionalized benzo[d]isoxazoles 1, sulfonyl azides 2, and terminal
alkynes 3 in the reaction (Table 3). Substitution on the benzoid ring of benzo[d]isoxazoles 1 such as 5-methylbenzo[d]isoxazole or 5-chlorobenzo[d]isoxazole
reacted with TsN32a and 1-butyl-4-ethynylbenzene 3 under the catalysis of CuBr to afford the corresponding
substituted 2-amino-4H-chromen-4-one imines 5a and 5b in 83 and 79% yields, respectively
(entries 1 and 2). A smooth reaction was observed in the three-component
reaction of 5-methylbenzo[d]isoxazole, 4-methoxybenzenesulfonyl
azide, and 1-butyl-4-ethynylbenzene, the desired product 5c was isolated in 95% yield (entry 3). The multicomponent cyclization
reaction of 5-methoxybenzo[d]isoxazole with TsN3 and 1-butyl-4-ethynylbenzene gave the targeted product 5e in 66% yield (entry 5). Interestingly, the result could
be improved to 94% (5f) when 1-ethynyl-4-methoxybenzene
was employed instead of 1-butyl-4-ethynylbenzene (entry 6). It seemed
that the electron-rich aryl azides that bear electron-donating groups
such as MeO or Me generally performed well compared to those of the
electron-deficient ones (entries 1–4 vs 5–7). Indeed,
when 4-bromobenzenesulfonyl azide was utilized as a nitrogen source
of the ketenimine intermediate, the corresponding products 5h, 5i, and 5j were produced in yields ranging
from 59 to 67% (entries 8–10). The scope of the azide counterpart
also turned out to be broad, the reaction of alkyl sulfonyl azide
(MsN3) with various benzo[d]isoxazoles
and aryl alkynes were readily employed with high efficiency and excellent
chemical selectivity (entries 11–15). Other than the 5-substituted
benzo[d]isoxazoles 1, functional groups
located at the other positions of the benzoid could be well tolerated
in the reaction. For example, the reactions of 6-Me or 7-MeO-substituted
benzo[d]isoxazole with TsN3 and aromatic
alkynes successfully afforded the desired products 5p and 5q in moderate to good yields, respectively (entries
16–17). The 7-methoxybenzo[d]isoxazole reacted
with MsN3 and 1-ethynyl-4-methoxybenzene smoothly to give
compound 5r in 47% yield (entry 18). In addition to these
results, 4-chlorobenzo[d]isoxazole 1s was found to react with TsN3 and an alkyl alkyne, hex-1-yne,
to produce the desired product 5s in 67% yield (Scheme 2, eq 1).

Scheme 2 Extended
Experiments
Table 3 Substrate
Scope Studiesa
entry	R1	R2	R3	yield (%)a	
1	5-Me	4-MeC6H4	nBu	83 (5a)	
2	5-Cl	4-MeC6H4	nBu	79 (5b)	
3	5-Me	4-MeOC6H4	nBu2	95 (5c)	
4	5-Me	C6H5	nBu	88 (5d)	
5	5-MeO	4-ClC6H4	nBu	66 (5e)	
6	5-MeO	4-ClC6H4	MeO	94 (5f)	
7	5-Me	4-ClC6H4	nBu	73 (5g)	
8	5-Me	4-BrC6H4	Me	59 (5h)	
9	5-Me	4-BrC6H4	nBu	67 (5i)	
10	5-Me	4-BrC6H4	F	62 (5j)	
11	5-Cl	Me	nBu	56 (5k)	
12	H	Me	Me	76 (5l)	
13	5-Cl	Me	Me	98 (5m)	
14	5-Cl	Me	H	76 (5n)	
15	5-Cl	Me	F	84 (5o)	
16	6-Me	4-MeC6H4	nBu	82 (5p)	
17	7-MeO	4-MeC6H4	H	43 (5q)	
18	7-MeO	Me	MeO	47 (5r)	
a Reaction conditions: benzo[d]isoxazole 1 (0.24 mmol), azide 2 (0.40 mmol), and terminal alkyne 3 (0.20 mmol) in 2.0
mL of DCE/DCM (v/v = 1:1) at 80 °C. Isolated yield of products 5 based on 3.

We were pleased to observe that this copper-catalyzed
three-component
cyclization reaction could be easily enlarged to gram-scale, without
the loss of catalytic efficiency and chemical selectivity. As can
be seen in Scheme 2, in the 5.0 mmol reaction of 1-butyl-4-ethynylbenzene 3a with benzo[d]isoxazole 1a and tosyl
azide 2a, the desired product 4a could be
isolated in 93% yield when 7.5 mol % of CuBr was employed as the catalyst
(Scheme 2, eq 2). On
the other hand, with an aim to broaden the utility of the product,
the Ts group was successfully removed to afford free 4-amino-3-arylcoumarins,
whose analogues showed good antiarrhythmic activity, platelet antiaggregating
activity and infiltration anesthesia activities in rats.25 It was found that the treatment of compound 4a with 5 N of H2SO4 in MeOH can give
free 4-amino-3-arylchromen-2-one 7 in 78% yield. (Scheme 2, eq 3).

Conclusions
In conclusion, we have developed a copper-catalyzed multicomponent
cascade cyclization reaction of benzo[d]isoxazoles
with azides and terminal alkynes. The reaction proceeds through sequential
azide–alkyne cycloaddition (CuAAC)/Kemp elimination/tandem
cyclization, thus providing efficient access to diversity-oriented
O-heterocycles 4-amino-2H-chromenone-2-imines. The
reaction tolerated a broad range of functional groups, and only released
N2 as the sole byproduct. Moreover, the reaction could
be easily extended to gram-scale and the afforded product could be
converted into medicinally active free 4-amino-2H-chromen-2-one in good yield.

Experimental Section
Unless otherwise
noted, commercial reagents were purchased from
Aldrich, Alfa Aesar, or other commercial suppliers, and were used
as received. Solvents were dried and distilled according to standard
procedures before use. Reactions were conducted using standard Schlenk
techniques on a vacuum line. Analytical thin-layer chromatography
(TLC) was performed using glass plates precoated with 0.25 mm 230–400
mesh silica gel impregnated with a fluorescent indicator (254 nm).
Flash column chromatography was performed using a silica gel (60 Å
pore size, 32–63 μm, standard grade). Organic solutions
were concentrated on rotary evaporators at ∼20 Torr (house
vacuum) at 25–35 °C. NMR spectra are recorded in parts
per million (ppm) from internal standard tetramethylsilane on the
δ scale. High-resolution mass spectrometry (HRMS) analysis was
performed by electrospray ionization (ESI-micrOTOF).

General Procedure for the
Preparation of 2-Imino-2H-chromen-4-amines 4 and 5
Sulfonyl
azide 2 (0.30 mmol, 1.5 equiv), terminal alkyne 3 (0.20 mmol, 1.0 equiv), CuBr (0.02 mmol, 10 mol %), and
benzo[d]isoxazole 1 (0.30 mmol, 1.5
equiv) were added to a solution of anhydrous solvent mixture of DCE/DCM
(2.0 mL, v/v = 1:1) at room temperature under N2. Then
triethylamine (0.60 mmol, 3.0 equiv) was slowly added by a syringe.
The reaction was stirred at 80 °C for about 2–4 h. After
completion of the reaction as indicated by TLC, the reaction mixture
was quenched with saturated NH4Cl solution (3.0 mL), and
extracted with ethyl acetate (3.0 mL × 3). The combined organic
layer was dried over Na2SO4, filtered, and concentrated.
The crude residue was purified by flash column chromatograph (EtOA/DCM
= 1:20, or recrystallization) to give the desired products 4 or 5.

N-(4-Amino-3-(p-tolyl)-2H-chromen-2-ylidene)-4-methylbenzenesulfonamide
(4a)
Yield: 89%; white solid, mp: 270–271
°C. 1H NMR (400 MHz, DMSO-d6) δ:
8.26 (d, J = 7.9 Hz, 1H), 7.81 (d, J = 7.9 Hz, 2H), 7.70 (t, J = 7.7 Hz, 1H), 7.43 (t, J = 8.9 Hz, 2H), 7.33–7.30 (m, 4H), 7.16 (d, J = 7.7 Hz, 2H), 2.38 (s, 3H), 2.32 (s, 3H). 13C NMR (100 MHz, DMSO-d6) δ: 159.3,
152.7, 152.0, 142.0, 141.7, 137.3, 133.5, 131.4, 130.0, 129.9, 129.5,
127.3, 125.6, 124.4, 116.9, 114.7, 99.9, 21.5, 21.4. HRMS calcd for
C23H21N2O3S (M + H)+: 405.1273, found: 405.1267.

N-(4-Amino-3-(4-methoxyphenyl)-2H-chromen-2-ylidene)-4-methylbenzenesulfonamide (4b)
Yield: 68%; white solid, mp: 218–219 °C. 1H NMR (400 MHz, DMSO-d6) δ:
8.18
(d, J = 8.0 Hz, 1H), 7.74 (d, J =
8.0 Hz, 2H), 7.62 (t, J = 7.7 Hz, 1H), 7.38–7.33
(m, 2H), 7.25 (d, J = 8.0 Hz, 2H), 7.12 (d, J = 8.5 Hz, 2H), 6.99 (d, J = 8.5 Hz, 2H),
3.75 (s, 3H), 2.25 (s, 3H). 13C NMR (100 MHz, DMSO-d6) δ: 159.4, 159.2, 152.9, 152.0, 142.0,
141.7, 133.4, 132.7, 129.5, 127.3, 125.6, 124.8, 124.4, 116.9, 115.0,
114.7, 99.7, 55.5, 21.4. HRMS calcd for C23H21N2O4S (M + H)+: 421.1222, found:
421.1217.

N-(4-Amino-3-phenyl-2H-chromen-2-ylidene)-4-methylbenzenesulfonamide
(4c)
Yield: 68%; white solid, mp: 261–262
°C. 1H NMR (400 MHz, DMSO-d6) δ: 8.31 (t, J = 9.8 Hz, 1H), 7.85 (d, J = 8.1 Hz, 2H), 7.72 (t, J = 7.7 Hz, 1H),
7.53 (t, J = 7.4 Hz, 2H), 7.47–7.41 (m, 3H),
7.34–7.21 (m, 4H), 2.32 (s, 3H). 13C NMR (100 MHz,
DMSO-d6) δ: 159.2, 152.7, 152.0,
142.0, 141.7, 133.6, 133.0, 131.6, 129.5, 128.2, 127.3, 125.7, 124.5,
117.0, 114.7, 100.0, 21.4. HRMS calcd for C22H19N2O3S (M + H)+: 391.1116, found:
391.1111.

N-(4-Amino-3-(4-butylphenyl)-2H-chromen-2-ylidene)-4-methylbenzenesulfonamide (4d)
Yield: 96%; white solid, mp: 92–93 °C. 1H NMR (400 MHz, CDCl3) δ: 7.84 (d, J = 8.1 Hz, 2H), 7.74 (d, J = 7.9 Hz, 1H),
7.44 (t, J = 7.7 Hz, 1H), 7.21–7.18 (m, 3H),
7.14–7.10
(m, 5H), 6.02–5.75 (br, 2H), 2.52 (t, J =
7.7 Hz, 2H), 2.34 (s, 3H), 1.56–1.52 (m, 2H), 1.38–1.26
(m, 2H), 0.91 (t, J = 7.3 Hz, 3H). 13C
NMR (100 MHz, CDCl3) δ: 159.6, 152.0, 151.6, 143.0,
142.1, 140.9, 132.3, 130.5, 129.3, 129.0, 128.7, 126.9, 125.0, 123.1,
116.8, 114.0, 101.4, 35.4, 33.4, 22.4, 21.5, 14.0. HRMS calcd for
C26H27N2O3S (M + H)+: 447.1742, found: 447.1737.

N-(4-Amino-3-(4-fluorophenyl)-2H-chromen-2-ylidene)-4-methylbenzenesulfonamide (4e)
Yield: 71%; white solid, mp: 301–302 °C. 1H NMR (400 MHz, DMSO-d6) δ:
8.26
(d, J = 6.0 Hz, 1H), 7.82 (d, J =
5.4 Hz, 2H), 7.70 (d, J = 6.7 Hz, 1H), 7.44–7.41
(m, 2H), 7.38–7.02 (m, 6H), 2.32 (s, 3H). 13C NMR
(100 MHz, DMSO-d6) δ: 162.3 (d, 1J = 243 Hz), 159.2, 153.0, 152.0, 142.0,
141.7, 133.8, 133.7, 133.6, 129.5, 129.2, 127.3, 125.7, 124.4, 116.5,
116.3 (d, 2J = 21 Hz), 114.7 (d, 2J = 23 Hz), 99.0, 21.4. HRMS calcd for C22H18FN2O3S (M + H)+: 409.1022, found: 409.1017.

N-(4-Amino-3-(4-bromophenyl)-2H-chromen-2-ylidene)-4-methylbenzenesulfonamide (4f)
Yield: 53%; yellow solid, mp: 284–285 °C. 1H NMR (400 MHz, DMSO-d6) δ:
8.25
(d, J = 8.0 Hz, 1H), 7.88–7.56 (m, 5H), 7.43–7.25
(m, 6H), 2.32 (s, 3H). 13C NMR (100 MHz, DMSO-d6) δ: 159.0, 152.8, 152.0, 142.1, 141.6, 133.9,
133.6, 132.4, 129.5, 128.5, 127.3, 125.7, 124.4, 121.7, 117.0, 114.7,
98.8, 21.4. HRMS calcd for C22H18BrN2O3S (M + H)+: 469.0222, found: 469.0216.

Methyl-4-(4-amino-2-(tosylimino)-2H-chromen-3-yl)benzoate
(4g)
Yield: 40%; white solid, mp: 268–269
°C. 1H NMR (400 MHz, DMSO-d6) δ: 8.27 (d, J = 8.0 Hz, 1H), 8.07 (d, J = 8.1 Hz, 2H), 7.81 (d, J = 8.1 Hz, 2H),
7.72 (t, J = 7.8 Hz, 1H), 7.48–7.43 (m, 4H),
7.32 (d, J = 8.0 Hz, 2H), 3.90 (s, 3H), 2.32 (s,
3H). 13C NMR (100 MHz, DMSO-d6) δ: 166.7, 158.8, 152.8, 152.1, 142.1, 141.6, 138.4, 133.7,
132.2, 130.3, 129.5, 129.3, 127.3, 125.7, 124.5, 117.1, 114.6, 98.9,
52.77, 21.4. HRMS calcd for C24H21N2O5S (M + H)+: 449.1171, found: 449.1166.

N-(4-Amino-3-(thiophen-3-yl)-2H-chromen-2-ylidene)-4-methylbenzenesulfonamide (4h)
Yield: 71%; yellow solid, mp: 246–247 °C. 1H NMR (400 MHz, DMSO-d6) δ: 8.27
(d, J = 8.0 Hz, 1H), 7.84 (d, J =
8.0 Hz, 2H), 7.75–7.64 (m, 2H), 7.55 (d, J = 1.6 Hz, 1H), 7.72–7.66 (m, 2H), 7.32 (d, J = 8.0 Hz, 2H), 7.12 (d, J = 4.8 Hz, 1H), 2.33 (s,
3H). 13C NMR (100 MHz, DMSO-d6) δ: 158.9, 153.0, 151.8, 142.0, 141.7, 133.6, 132.1, 130.3,
129.5, 127.3, 126.6, 126.4, 125.7, 124.4, 117.1, 114.5, 95.0, 21.4.
HRMS calcd for C20H17N2O3S2 (M + H)+: 397.0681, found: 397.0675.

N-(4-Amino-3-hexyl-2H-chromen-2-ylidene)-4-methylbenzenesulfonamide
(4i)
Yield: 62%; white solid, mp: 188–189
°C. 1H NMR (400 MHz, DMSO-d6) δ: 8.15 (d, J = 8.1 Hz, 1H), 7.85 (d, J = 7.5 Hz, 2H), 7.64 (t, J = 7.8 Hz, 1H),
7.47–7.29 (m, 4H), 2.49 (d, J = 8.2 Hz, 2H),
2.31 (s, 3H), 1.40–1.25 (m, 8H), 0.84 (t, J = 6.2 Hz, 3H). 13C NMR (100 MHz, DMSO-d6) δ: 159.7, 151.9, 151.6, 141.9, 132.8, 129.4,
127.2, 125.4, 123.7, 116.9, 114.8, 98.7, 31.8, 28.9, 27.1, 24.2, 22.6,
21.4, 14.4. HRMS calcd for C22H27N2O3S (M + H)+: 399.1742, found: 399.1737.

N-(4-Amino-3-cyclopropyl-2H-chromen-2-ylidene)-4-methylbenzenesulfonamide(4j)
Yield: 65%; white solid, mp: 242–243 °C. 1H NMR (400 MHz, DMSO-d6) δ:
8.18
(d, J = 8.0 Hz, 1H), 7.86 (d, J =
7.8 Hz, 2H), 7.64 (t, J = 7.8 Hz, 1H), 7.40 (t, J = 7.6 Hz, 1H), 7.33 (t, J = 7.6 Hz, 3H),
2.32 (s, 3H), 1.32–1.30 (m, 1H), 1.00 (d, J = 7.0 Hz, 2H), 0.54 (d, J = 4.7 Hz, 2H). 13C NMR (100 MHz, DMSO-d6) δ: 159.8,
154.5, 151.8, 142.0, 141.8, 132.9, 129.4, 127.2, 125.4, 123.8, 116.8,
114.75, 97.7, 21.4, 8.8, 6.6. HRMS calcd for C19H19N2O3S (M + H)+: 355.1116, found:
355.1111.

N-(4-Amino-3-(4-butylphenyl)-6-methyl-2H-chromen-2-ylidene)-4-methylbenzenesulfonamide (5a)
Yield: 83%; white solid, mp: 210–211 °C. 1H NMR (400 MHz, CDCl3) δ: 7.85 (d, J = 8.2 Hz, 2H), 7.54 (s, 1H), 7.27 (d, J = 8.2 Hz, 1H), 7.17 (d, J = 8.1 Hz, 2H), 7.12 (d, J = 8.5 Hz, 1H), 7.17–6.96 (m, 4H), 5.90–7.76
(br, 2H), 2.49 (t, J = 7.7 Hz, 2H), 2.33 (s, 3H),
2.25 (s, 3H), 1.54–1.50 (m, 2H), 1.35–1.30 (m, 2H),
0.91 (t, J = 7.3 Hz, 3H). 13C NMR (100
MHz, CDCl3) δ: 159.7, 151.6, 150.3, 142.8, 141.9,
141.0, 135.0, 133.5, 130.5, 129.2, 128.9, 128.8, 127.0, 122.8, 116.5,
113.7, 101.4, 35.4, 33.4, 22.4, 21.4, 20.9, 14.0. HRMS calcd for C27H29N2O3S (M + H)+: 461.1899, found: 461.1893.

N-(4-Amino-3-(4-butylphenyl)-6-chloro-2H-chromen-2-ylidene)-4-methylbenzenesulfonamide (5b)
Yield: 79%; white solid, mp: 229–230 °C. 1H NMR (400 MHz, CDCl3) δ: 7.87 (d, J = 8.1 Hz, 2H), 7.73 (d, J = 1.8 Hz, 1H),
7.43 (dd, J = 8.8, 1.9 Hz, 1H), 7.22–7.20
(m, 3H), 7.12–7.01 (m, 4H), 5.92–5.74 (br, 2H), 2.44
(t, J = 7.6 Hz, 2H), 2.35 (s, 3H), 1.53–1.45
(m, 2H), 1.35–1.26 (m, 2H), 0.90 (t, J = 7.3
Hz, 3H). 13C NMR (100 MHz, CDCl3) δ: 159.3,
150.5, 150.5, 143.2, 142.3, 140.5, 132.3, 130.5, 130.3, 129.3, 129.0,
128.3, 127.1, 123.1, 118.2, 115.3, 101.9, 35.3, 33.4, 22.3, 21.5,
14.0. HRMS calcd for C26H26ClN2O3S (M + H)+: 481.1353, found: 481.1347.

N-(4-Amino-3-(4-butylphenyl)-6-methyl-2H-chromen-2-ylidene)-4-methoxybenzenesulfonamide (5c)
Yield: 95%; white solid, mp: 198–199 °C. 1H NMR (400 MHz, DMSO-d6) δ:
8.11 (s, 1H), 7.86 (d, J = 8.7 Hz, 2H), 7.51 (d, J = 8.4 Hz, 1H), 7.35–7.30 (m, 3H), 7.17 (d, J = 7.8 Hz, 2H), 7.03 (d, J = 8.7 Hz, 2H),
3.78 (s, 3H), 2.64 (t, J = 7.7 Hz, 2H), 2.38 (s,
3H), 1.67–1.60 (m, 2H), 1.42–1.36 (m, 2H), 0.94 (t, J = 7.3 Hz, 3H). 13C NMR (100 MHz, DMSO-d6) δ: 161.9, 159.2, 152.5, 150.2, 142.1,
136.5, 135.0, 134.2, 131.3, 130.2, 129.3, 124.0, 116.7, 114.3, 114.1,
99.9, 55.9, 35.3, 33.4, 22.5, 21.0, 14.3. HRMS calcd for C27H28N2O4SNa (M + Na)+:
499.1667, found: 499.1662.

N-(4-Amino-3-(4-butylphenyl)-6-methyl-2H-chromen-2-ylidene)benzenesulfonamide (5d)
Yield: 88%; white solid, mp: 105–106 °C. 1H NMR (400 MHz, CDCl3) δ: 7.96 (d, J = 7.0 Hz, 2H), 7.54 (s, 1H), 7.42–7.37 (m, 3H), 7.27 (d, J = 9.0 Hz, 1H), 7.20–7.04 (m, 5H), 6.02–5.78
(br, 2H), 2.51 (t, J = 7.6 Hz, 2H), 2.26 (s, 3H),
1.55–1.52 (m, 2H), 1.36–1.31 (m, 2H), 0.91 (t, J = 7.2 Hz, 3H). 13C NMR (100 MHz, CDCl3) δ: 159.8, 151.6, 150.3, 143.9, 142.9, 135.1, 133.6, 131.5,
130.5, 129.2, 128.7, 128.3, 126.9, 122.7, 116.6, 113.6, 101.5, 35.4,
33.4, 22.4, 20.9, 14.0. HRMS calcd for C26H26N2O3SNa (M + Na)+: 469.1562, found:
469.1556.

N-(4-Amino-3-(4-butylphenyl)-6-methoxy-2H-chromen-2-ylidene)-4-chlorobenzenesulfonamide (5e)
Yield: 66%; white solid, mp: 267–268 °C. 1H NMR (400 MHz, DMSO-d6) δ:
8.21 (d, J = 9.0 Hz, 1H), 7.94 (d, J = 8.3 Hz, 2H), 7.58 (d, J = 8.3 Hz, 2H), 7.30 (d, J = 7.6 Hz, 2H), 7.17 (d, J = 7.7 Hz, 2H),
7.06 (d, J = 8.0 Hz, 1H), 6.84 (s, 1H), 3.92 (s,
3H), 2.63 (t, J = 7.5 Hz, 2H), 1.66–1.59 (m,
2H), 1.41–1.33 (m, 2H), 0.94 (t, J = 7.2 Hz,
3H). 13C NMR (100 MHz, DMSO-d6) δ: 163.5, 159.5, 153.8, 153.5, 143.7, 142.1, 136.6, 131.5,
120.0, 129.3, 129.1, 125.9, 114.1, 107.7, 100.3, 98.4, 56.7, 35.3,
33.4, 22.5, 14.3. HRMS calcd for C26H26ClN2O4S (M + H)+: 497.1302, found: 497.1296.

N-(4-Amino-6-methoxy-3-(4-methoxyphenyl)-2H-chromen-2-ylidene)-4-chlorobenzenesulfonamide (5f)
Yield: 94%; white solid, mp: 237–238 °C. 1H NMR (400 MHz, DMSO-d6) δ:
8.19 (d, J = 9.0 Hz, 1H), 7.95 (d, J = 8.5 Hz, 2H), 7.59 (d, J = 8.5 Hz, 2H), 7.18 (d, J = 8.5 Hz, 2H), 7.10–6.95 (m, 3H), 6.83 (d, J = 2.1 Hz, 1H), 3.92 (s, 3H), 3.82 (s, 3H). 13C NMR (100 MHz, DMSO-d6) δ: 163.4,
159.6, 159.2, 153.7, 143.7, 136.6, 132.8, 129.3, 129.1, 125.9, 124.7,
114.9, 114.0, 107.8, 100.3, 98.2, 56.6, 55.5. HRMS calcd for C23H20ClN2O5S (M + H)+: 471.0781, found: 471.0776.

N-(4-Amino-3-(4-butylphenyl)-6-methyl-2H-chromen-2-ylidene)-4-chlorobenzenesulfonamide (5g)
Yield: 73%; white solid, mp: 219–220 °C. 1H NMR (400 MHz, DMSO-d6) δ:
8.31 (s, 1H), 8.09 (d, J = 8.0 Hz, 1H), 7.91 (d, J = 8.3 Hz, 2H), 7.58–7.52 (m, 3H), 7.34–7.30
(m, 2H), 7.18 (d, J = 7.7 Hz, 2H), 2.64 (t, J = 7.6 Hz, 2H), 2.39 (s, 3H), 1.67–1.60 (m, 2H),
1.43–1.36 (m, 2H), 0.94 (t, J = 7.3 Hz, 3H). 13C NMR (100 MHz, DMSO-d6) δ:
159.6, 153.2, 150.2, 143.6, 142.2, 136.6, 135.3, 134.5, 131.3, 130.0,
129.4, 129.2, 129.1, 124.1, 116.7, 114.3, 100.0, 35.3, 33.4, 22.4,
21.0, 14.3. HRMS calcd for C26H25ClN2O3SNa (M + Na)+: 503.1172, found: 503.1167.

N-(4-Amino-6-methyl-3-(p-tolyl)-2H-chromen-2-ylidene)-4-bromobenzenesulfonamide (5h)
Yield: 59%; yellow solid, mp: 281–282 °C. 1H NMR (400 MHz, DMSO-d6) δ:
8.12 (s, 1H), 7.85 (d, J = 8.4 Hz, 2H), 7.72 (d, J = 8.4 Hz, 2H), 7.52 (d, J = 8.5 Hz, 1H),
7.35–7.29 (m, 3H), 7.16 (d, J = 7.8 Hz, 2H),
2.38 (s, 6H). 13C NMR (100 MHz, DMSO-d6) δ: 159.6, 153.2, 150.2, 144.0, 137.4, 135.3,
134.5, 132.1, 131.4, 130.1, 129.8, 129.4, 125.5, 124.1, 116.7, 114.3,
100.0, 21.4, 21.0. HRMS calcd for C23H20BrN2O3S (M + H)+: 483.0378, found: 483.0373.

N-(4-Amino-3-(4-butylphenyl)-6-methyl-2H-chromen-2-ylidene)-4-bromobenzenesulfonamide (5i)
Yield: 67%; yellow solid, mp: 221–222 °C. 1H NMR (400 MHz, DMSO-d6) δ:
8.13 (s, 1H), 7.84 (d, J = 8.3 Hz, 2H), 7.71 (d, J = 8.4 Hz, 2H), 7.53 (d, J = 8.4 Hz, 1H),
7.34–7.30 (m, 3H), 7.18 (d, J = 7.8 Hz, 2H),
2.64 (t, J = 7.6 Hz, 2H), 2.39 (s, 3H), 1.66–1.62
(m, 2H), 1.42–1.36 (m, 2H), 0.95 (t, J = 7.3
Hz, 3H). 13C NMR (100 MHz, DMSO-d6) δ: 159.6, 153.2, 150.2, 144.0, 142.2, 135.3, 134.5,
132.1, 131.3, 123.0, 129.4, 125.5, 124.1, 116.7, 114.3, 100.0, 35.3,
33.4, 22.4, 21.0, 14.3. HRMS calcd for C26H26BrN2O3S (M + H)+: 525.0848, found:
525.0842.

N-(4-Amino-3-(4-fluorophenyl)-6-methyl-2H-chromen-2-ylidene)-4-bromobenzenesulfonamide (5j)
Yield: 62%; yellow solid, mp: 278–279 °C. 1H NMR (400 MHz, DMSO-d6) δ:
8.12 (s, 1H), 7.85 (d, J = 8.5 Hz, 2H), 7.72 (d, J = 8.5 Hz, 2H), 7.54 (d, J = 8.5 Hz, 1H),
7.36–7.31 (m, 5H), 2.39 (s, 3H). 13C NMR (100 MHz,
DMSO-d6) δ: 162.5 (d, 1J = 243 Hz), 159.5, 153.5, 150.3, 143.9, 135.3,
134.6, 133.8, 133.7, 132.1, 129.4, 124.9 (d, 2J = 23 Hz), 116.7, 116.3 (d, 2J = 21 Hz),
114.3, 100.0, 99.1, 21.0. HRMS calcd for C22H17BrFN2O3S (M + H)+: 487.0127, found:
487.0122.

N-(4-Amino-3-(4-butylphenyl)-6-chloro-2H-chromen-2-ylidene)methanesulfonamide (5k)
Yield: 56%; white solid, mp: 210–211 °C. 1H NMR (400 MHz, DMSO-d6) δ: 8.48
(s, 1H), 7.77 (d, J = 8.8 Hz, 1H), 7.61 (d, J = 8.9 Hz, 1H), 7.30 (d, J = 7.7 Hz, 2H),
7.20 (d, J = 7.7 Hz, 2H), 3.00 (s, 3H), 2.63 (t, J = 7.6 Hz, 2H), 1.67–1.59 (m, 2H), 1.41–1.36
(m, 2H), 0.94 (t, J = 7.3 Hz, 3H). 13C
NMR (100 MHz, DMSO-d6) δ: 159.1,
151.3, 150.7, 142.2, 132.9, 131.2, 130.0, 129.8, 129.3, 123.9, 119.4,
116.4, 100.2, 43.0, 35.3, 33.4, 22.5, 14.3. HRMS calcd for C20H22ClN2O3S (M + H)+:
405.1040, found: 405.1034.

N-(4-Amino-3-(p-tolyl)-2H-chromen-2-ylidene)methanesulfonamide
(5l)
Yield 76%; white solid, mp: 214–215
°C. 1H NMR (400 MHz, DMSO-d6) δ: 8.30
(d, J = 8.1 Hz, 1H), 7.74 (t, J =
7.7 Hz, 1H), 7.56 (d, J = 8.3 Hz, 1H), 7.48 (t, J = 7.6 Hz, 1H), 7.30 (d, J = 7.8 Hz, 2H),
7.19 (d, J = 7.8 Hz, 2H), 2.99 (s, 3H), 2.38 (s,
3H). 13C NMR (100 MHz, DMSO-d6) δ: 159.5, 152.3, 152.1, 137.2, 133.3, 131.4, 130.0, 125.6,
124.3, 117.4, 114.8, 99.7, 79.7, 43.0, 21.4. HRMS calcd for C17H17N2O3S (M + H)+: 329.0960, found: 329.0954.

N-(4-Amino-6-chloro-3-(p-tolyl)-2H-chromen-2-ylidene)methanesulfonamide
(5m)
Yield: 98%; white solid, mp: 286–287
°C. 1H NMR (400 MHz, DMSO-d6) δ: 8.47
(d, J = 2.1 Hz, 1H), 7.78–7.75 (m, 1H), 7.60
(d, J = 8.9 Hz, 1H), 7.29 (d, J =
7.9 Hz, 2H), 7.18 (d, J = 7.9 Hz, 2H), 2.99 (s, 3H),
2.37 (s, 3H). 13C NMR (100 MHz, DMSO-d6) δ: 159.1, 151.3, 150.7, 137.3, 132.9, 131.3,
130.0, 129.8, 123.9, 119.4, 116.4, 100.2, 43.0, 21.4. HRMS calcd for
C17H16ClN2O3S (M + H)+: 363.0570, found: 363.0565.

N-(4-Amino-6-chloro-3-phenyl-2H-chromen-2-ylidene)methanesulfonamide (5n)
Yield: 76%; white solid, mp: 230–231 °C. 1H NMR (400 MHz, DMSO-d6) δ: 8.48
(d, J = 2.1 Hz, 1H), 8.32 (s, 1H), 7.79–7.76
(m, 1H), 7.61 (d, J = 8.9 Hz, 1H), 7.49 (t, J = 7.5 Hz, 2H), 7.40 (t, J = 7.3 Hz, 1H),
7.30 (d, J = 7.3 Hz, 1H), 2.99 (s, 3H). 13C NMR (100 MHz, DMSO-d6) δ: 159.0,
151.2, 150.8, 133.0, 132.8, 131.5, 129.8, 129.4, 128.2, 123.9, 119.4,
116.4, 100.3, 79.7, 43.0. HRMS calcd for C16H14ClN2O3S (M + H)+: 349.0414, found:
349.0408.

N-(4-Amino-6-chloro-3-(4-fluorophenyl)-2H-chromen-2-ylidene)methanesulfonamide (5o)
Yield: 84%; white solid, mp: 268–269 °C. 1H NMR (400 MHz, DMSO-d6) δ: 8.46
(s, 1H), 8.32 (s, 1H), 7.77 (d, J = 8.1 Hz, 1H),
7.61 (d, J = 8.7 Hz, 1H), 7.42–7.25 (m, 3H),
2.99 (s, 3H). 13C NMR (100 MHz, DMSO-d6) δ: 162.2 (d, 1J =
243 Hz), 159.0, 151.6, 150.8, 133.7, 133.6, 129.8, 129.1, 123.9, 119.5,
116.3 (d, 2J = 21 Hz), 99.3, 79.8, 43.0.
HRMS calcd for C16H13ClFN2O3S (M + H)+: 367.0319, found: 367.0314.

N-(4-Amino-3-(4-butylphenyl)-7-methyl-2H-chromen-2-ylidene)-4-methylbenzenesulfonamide (5p)
Yield: 82%; white solid, mp: 109–110 °C. 1H NMR (400 MHz, DMSO-d6) δ:
8.14 (d, J = 8.6 Hz, 1H), 7.80 (d, J = 8.0 Hz, 2H), 7.33–7.26 (m, 6H), 7.18 (d, J = 7.9 Hz, 2H), 5.75 (br, 2H), 2.65 (t, J = 7.7
Hz, 2H), 2.46 (s, 3H), 2.33 (s, 3H), 1.67–1.63 (m, 2H), 1.42–1.37
(m, 2H), 0.95 (t, J = 7.3 Hz, 3H). 13C
NMR (100 MHz, DMSO-d6) δ: 159.4,
152.8, 152.1, 144.4, 142.1, 141.9, 131.4, 130.1, 129.4, 129.3, 127.2,
126.8, 124.2, 116.8, 112.2, 99.4, 35.3, 33.4, 22.4, 21.5, 21.4, 14.3.
HRMS calcd for C27H29N2O3S (M+H)+: 461.1893, found: 461.1899.

N-(4-Amino-8-methoxy-3-phenyl-2H-chromen-2-ylidene)-4-methylbenzenesulfonamide
(5q)
Yield: 43%; white solid, mp: >320 °C. 1H NMR (400
MHz, DMSO-d6) δ: 7.89 (d, J = 8.0 Hz, 2H), 7.80–7.78 (m, 1H), 7.53–7.47
(m, 2H), 7.43–7.37 (m, 3H), 7.29–7.23 (m, 4H), 4.02
(s, 3H), 2.33 (s, 3H). 13C NMR (100 MHz, DMSO-d6) δ: 158.8, 152.8, 147.9, 142.3, 141.8, 141.2,
133.1, 131.5, 129.5, 129.0, 128.2, 127.7, 125.5, 115.6, 115.4, 115.0,
100.4, 56.8, 21.4. HRMS calcd for C23H21N2O4S (M + H)+: 421.1217, found: 421.1219.

N-(4-Amino-8-methoxy-3-(4-methoxyphenyl)-2H-chromen-2-ylidene)methanesulfonamide (5r)
Yield: 47%; white solid, mp: 227–228 °C. 1H NMR (400 MHz, DMSO-d6) δ: 7.84–7.82
(m, J = 6.4, 2.6 Hz, 1H), 7.40 (d, J = 6.4 Hz, 2H), 7.21 (d, J = 8.5 Hz, 2H), 7.05 (d, J = 8.5 Hz, 2H), 3.97 (s, 3H), 3.82 (s, 3H), 3.15 (s, 3H). 13C NMR (100 MHz, DMSO-d6) δ:
159.2, 159.0, 152.8, 147.9, 142.2, 132.7, 125.4, 124.9, 115.7, 115.3,
115.2, 114.9, 99.5, 57.2, 55.6, 42.6. HRMS calcd for C18H19N2O5S (M + H)+: 375.1009,
found: 375.1012.

N-(4-Amino-3-butyl-5-chloro-2H-chromen-2-ylidene)-4-methylbenzenesulfonamide (5s)
Yield: 67%; white solid, mp: 181–182 °C. 1H NMR (400 MHz, DMSO-d6) δ:
7.85
(d, J = 8.1 Hz, 2H), 7.62 (br, 2H), 7.58 (d, J = 8.2 Hz, 1H), 7.47 (d, J = 7.7 Hz, 1H),
7.36–7.32 (m, 3H), 2.33 (s, 3H), 1.40–1.31 (m, 6H),
0.90 (t, J = 6.6 Hz, 3H). 13C NMR (100
MHz, DMSO-d6) δ: 158.4, 153.3, 151.2,
142.1, 141.6, 132.8, 129.5, 129.5, 128.9, 127.1, 117.1, 112.2, 100.3,
28.9, 24.0, 22.4, 21.4, 14.5. HRMS calcd for C20H22ClN2O3S (M + H)+: 405.1034, found:
405.1039.

Gram-Scale Synthesis of Compound 4a
Tosyl
azide 2a (TsN3, 7.5 mmol, 1.5 equiv), 1-butyl-4-ethynylbenzene 3a (5 mmol, 1.0 equiv), CuBr (0.50 mmol, 10 mol %), and benzo[d]isoxazole 1a (7.5 mmol, 1.5 equiv) were added
to a solution of anhydrous DCE/DCM (10 mL, v/v = 1:1) at room temperature
under N2. Then TEA (15 mmol, 3.0 equiv) was slowly added
by a syringe. The reaction mixture was stirred at 80 °C for about
2–4 h. After completion of the reaction as indicated by TLC,
the reaction mixture was quenched with saturated NH4Cl
(30 mL), and extracted with ethyl acetate (30.0 mL × 3). The
crude residue was purified by column chromatography (ethyl acetate/DCM,
1:20) to give the desired product 4a (2.1 g, 94% yield)
as a white solid.

General Procedure for the Hydrolysis of 2-Imino-2H-chromen-4-amine 4a
To a screw-capped
Schlenk
tube 2-imino-2H-chromen-4-amine 4a (0.30
mmol, 134 mg) and MeOH (0.5 mL) were added. Then H2SO4 (0.5 mL, 50% aqueous solution) was added at room temperature.
The reaction mixture was heated to 100 °C and stirred overnight
under N2. Upon completion, the reaction mixture was cooled
down to room temperature, concentrated under vacuum to remove the
volatile component. Then quenched with solid Na2CO3 to pH = 10. The reaction was extracted with ethyl acetate
(5 mL × 3). The crude residue was purified by column chromatography
to give the desired product 7 as a white solid (68.5
mg, 78% yield).

4-Amino-3-(4-butylphenyl)-2H-chromen-2-one 7
Yield: 78%; white solid, mp:
154–155 °C. 1H NMR (400 MHz, CDCl3) δ: 7.58–7.50
(m, 2H), 7.32–7.22 (m, 6H), 5.21 (br, 2H), 2.60 (t, J = 8.0 Hz, 2H), 1.61–1.55 (m, 2H), 1.42–1.33
(m, 2H), 0.93 (t, J = 7.3 Hz, 3H). 13C
NMR (100 MHz, CDCl3) δ: 162.4, 153.1, 150.2, 142.8,
131.7, 130.4, 129.9, 129.3, 123.6, 121.9, 117.4, 114.4, 100.6, 35.5,
33.5, 22.5, 14.0. HRMS calcd for C19H19N NaO2 (M + Na)+: 316.1313, found: 316.1308.

Supporting Information Available
The
Supporting Information
is available free of charge on the ACS Publications website at DOI: 10.1021/acsomega.8b01179.1H, 13C NMR spectra and X-ray
Oak Ridge thermal ellipsoid plot of 4d (PDF)



Supplementary Material
ao8b01179_si_001.pdf

 The authors
declare no competing financial interest.

Acknowledgments
We thank the
China Postdoctoral Science Foundation (2017M612155),
and the Jiangxi Province Postdoctoral Science Foundation (2016RC37)
for financial support.
==== Refs
References
a Yu D. ; Suzuki M. ; Xie L. ; Morris-Natschke S. ; Lee K.-H. 
Recent progress in the development of coumarin derivatives
as potent anti-HIV agents . Med. Res. Rev. 
2003 , 23 , 322 –345 . 10.1002/med.10034 .12647313 b Coumarins: Biology, Applications, and Mode of Action ; O’Kennedy R. ; Thomas R. D.  , Eds.; Wiley : Chichester, U.K. , 1997 .
Dauzonne D. ; Folléas B. ; Martinez L. ; Chabot G. 
Synthesis and in vitro
cytotoxicity of a series of 3-aminoflavones . Eur. J. Med. Chem. 
1997 , 32 , 71 –82 . 10.1016/S0223-5234(97)84363-2 .
a Hayashi K. ; Mori J. ; Saito H. ; Hayashi T. 
Antiviral
targets of a chromene derivative from Sargassum micracanthum in the replication of human cytomegalovirus . Biol. Pharm. Bull. 
2006 , 29 , 1843 10.1248/bpb.29.1843 .16946496  b Inaba T. ; Tanaka K. ; Takeno R. ; Nagaki H. ; Yoshida C. ; Takano S. 
Synthesis and antiinflammatory activity
of 7-methanesulfonylamino-6-phenoxychromones. Antiarthritic effect
of the 3-formylamino compound (T-614) in chronic inflammatory disease
models . Chem. Pharm. Bull. 
2000 , 48 , 131 10.1248/cpb.48.131 .10705489  c Tanaka K. ; Yamamoto T. ; Aikawa Y. ; Kizawa K. ; Muramoto K. ; Matsuno H. ; Muraguchi A. 
Inhibitory
effects of an anti-rheumatic agent T-614 on immunoglobulin production
by cultured B cells and rheumatoid synovial tissues engrafted into
SCID mice . Rheumatology 
2003 , 42 , 1365 10.1093/rheumatology/keg381 .12810927 
Aikawa Y. ; Yamamoto M. ; Yamamoto T. ; Morimoto K. ; Tanaka K. 
An anti-rheumatic
agent T-614 inhibits NF-κB activation in LPS- and TNF-α-stimulated
THP-1 cells without interfering with IκBα degradation . Inflammation Res. 
2002 , 51 , 188 –194 . 10.1007/PL00000291 .
a Peng S. ; Wang L. ; Huang J. ; Sun S. ; Guo H. ; Wang J. 
Palladium-Catalyzed Oxidative Annulation
via C-H/N-H
Functionalization: Access to Substituted Pyrroles . Adv. Synth. Catal. 
2013 , 355 , 2550 –2557 . 10.1002/adsc.201300512 . b Hua C. ; Zhang K. ; Xin M. ; Ying T. ; Gao J. ; Jia J. ; Li Y. 
High quantum
yield and pH sensitive fluorescence dyes based on coumarin derivatives:
fluorescence characteristics and theoretical study . RSC Adv. 
2016 , 6 , 49221 –49227 . 10.1039/C6RA05996A . c Saha M. ; Pradhan K. ; Das A. R. 
Facile and eco-friendly
synthesis of chromeno[4,3-b]pyrrol-4(1H)-one derivatives applying magnetically recoverable nano crystalline
CuFe2O4 involving a domino three-component reaction
in aqueous media . RSC Adv. 
2016 , 6 , 55033 –55038 . 10.1039/C6RA06979G .
a Baskar B. ; Wittstein K. ; Sankar M. ; Khedkar V. ; Schürmann M. ; Kumar K. 
Stereoselective Cascade Double-Annulations
Provide Diversely Ring-Fused Tetracyclic Benzopyrones . Org. Lett. 
2012 , 14 , 5924 10.1021/ol3028412 .23151202  b Vedachalam S. ; Zeng J. ; Gorityala B. ; Antonio M. ; Liu X. 
N-Heterocyclic Carbene-Catalyzed
Intramolecular Aldehyde-Nitrile Cross Coupling: An Easy Access to
3-Aminochromones . Org. Lett. 
2010 , 12 , 352 –355 . 10.1021/ol9026232 .20025237  c Robinson C. W. ; Rye C. S. ; Chessum N. E. A. ; Jones K. 
A model β-sheet
interaction and thermodynamic analysis of β-strand mimetics . Org. Biomol. Chem. 
2015 , 13 , 7402 –7407 . 10.1039/C5OB00886G .26088610  d Wang Q. ; Zhang Z. ; Zhang X. ; Zhang J. ; Kang Y. ; Peng J. 
Synthesis of 7a-phenyl-1a,7a-dihydro-benzopyrano[2,3-b]azirin-7-ones via photoisomerization reaction . RSC Adv. 
2015 , 5 , 4788 –4794 . 10.1039/C4RA12542H .
a Wang L. ; Liu X. ; Dong Z. ; Fu X. ; Feng X. 
Asymmetric intramolecular oxa-Michael addition of activated
α,β-unsaturated
ketones catalyzed by a chiral N,N′-dioxide nickel (II) complex: highly enantioselective synthesis
of flavanones . Angew. Chem., Int. Ed. 
2008 , 47 , 8670 –8673 . 10.1002/anie.200803326 . b Biddle M. M. ; Lin M. ; Scheidt K. 
Catalytic Enantioselective Synthesis of Flavanones
and Chromanones . J. Am. Chem. Soc. 
2007 , 129 , 3830 –3831 . 10.1021/ja070394v .17348659  c Butler J. D. ; Conrad W. ; Lodewyk M. ; Fettinger J. ; Tantillo D. ; Kurth M. 
Synthesis of Substituted Chromanones:
An Organocatalytic Aldol/oxa-Michael Reaction . Org. Lett. 
2010 , 12 , 3410 –3413 . 10.1021/ol101221c .20617821 
a Hardman-Baldwin A. M. ; Visco M. ; Wieting J. ; Stern C. ; Kondo S. ; Mattson A. 
Silanediol-catalyzed
chromenone functionalization . Org. Lett. 
2016 , 18 , 3766 –3769 . 10.1021/acs.orglett.6b01783 .27453257  b He L. ; Zhao L. ; Wang D. ; Wang M.-X. 
Catalytic
Asymmetric Difunctionalization of Stable Tertiary Enamides with Salicylaldehydes:
Highly Efficient, Enantioselective, and Diastereoselective Synthesis
of Diverse 4-Chromanol Derivatives . Org. Lett. 
2014 , 16 , 5972 –5975 . 10.1021/ol5029964 .25358127 
Guo D. ; Chen T. ; Ye D. ; Xu J. ; Jiang H. ; Chen K. ; Wang H. ; Liu H. 
Cell-Permeable Iminocoumarine-Based
Fluorescent Dyes for Mitochondria . Org. Lett. 
2011 , 13 , 2884 –2887 . 10.1021/ol200908r .21548645 
Murugavel G. ; Punniyamurthy T. 
Novel copper-catalyzed multicomponent cascade synthesis
of iminocoumarin aryl methyl ethers . Org. Lett. 
2013 , 15 , 3828 –3831 . 10.1021/ol4014359 .23875790 
Wen L. R. ; Man N. ; Yuan W. ; Li M. 
Direct Construction of 2-Aryliminochromenes
from Arynes, N,S-Keteneacetals, and DMF Quick View Other Sources . J. Org. Chem. 
2016 , 81 , 5942 10.1021/acs.joc.6b00843 .27266363 
Peng W. ; Świtalska M. ; Wang L. ; Mei Z. ; Edazawa Y. ; Pang C. ; El-Sayed I. T. ; Wietrzyk J. ; Inokuchi T. 
Synthesis
and in vitro antiproliferative activity of new 11-aminoalkylamino-substituted
chromeno[2,3-b]indoles . Eur. J. Med. Chem. 
2012 , 58 , 441 –451 . 10.1016/j.ejmech.2012.10.023 .23151321 
For selective examples:

a Zhou H. ; Chen W. ; Chen Z. 
Pd/Norbornene Collaborative
Catalysis
on the Divergent Preparation of Heterocyclic Sulfoximine Frameworks . Org. Lett. 
2018 , 20 , 2590 –2594 . 10.1021/acs.orglett.8b00776 .29664649  b Tu Z. ; Tan J. ; Chen Z. ; Tu T. 
Iridium-Catalyzed
Regio- and Stereoselective C-H Oxidative Reaction to (Z)-3-Arylidene-2-oxindole
Imides under Neutral Conditions . Adv. Synth.
Catal. 
2017 , 359 , 4294 –4299 . 10.1002/adsc.201700983 . c Huang J. ; Huang Y. ; Wang T. ; Huang Q. ; Wang Z. ; Chen Z. 
Microwave-assisted Cp*CoIII-Catalyzed
C-H Activation/Double C-N Bond Formation Reactions to Thiadiazine-1-oxides . Org. Lett. 
2017 , 19 , 1128 –1131 . 10.1021/acs.orglett.7b00120 .28212044  d Zhu H. ; Chen Z. 
DDQ-Mediated Oxidative Radical Cycloisomerization
of 1,5-Diynols: Regioselective Synthesis of Benzo[b]fluorenones under
Metal-Free Conditions . Org. Lett. 
2016 , 18 , 488 –491 . 10.1021/acs.orglett.5b03533 .26815082  e Huang J. ; Yang Y. ; Chen Z. 
Rh(II)-Catalyzed Regioselective
Carbenoid Insertion Reaction of Simple Indoles with N-Sulfonyltriazoles:
A Rapid Access to Tryptamine Vinylogues . Adv.
Synth. Catal. 
2016 , 358 , 201 –206 . 10.1002/adsc.201500792 . f Xiao Q. ; Zhu H. ; Li G. ; Chen Z. 
Synthesis
of Trifluoromethanesulfanyl Benzofulvenes via a Cascade Electrophilic
Cyclization under Mild Conditions . Adv. Synth.
Catal. 
2014 , 356 , 3809 –3815 . 10.1002/adsc.201400561 . g Xiao Q. ; Sheng J. ; Chen Z. ; Wu J. 
Generation
of 4-((Trifluoro- methyl)thio)-2H-benzo[e][1,2]thiazine 1,1-Dioxides via a Reaction of Trifluoromethanesulfanylamide
with 2-(2-Alkynyl)benzenesulfonamide . Chem.
Commun. 
2013 , 49 , 8647 –8649 . 10.1039/c3cc44263b .
For selective examples
on Huisgen cycloadditions:

a Rostovtsev V. V. ; Green L. G. ; Fokin V. V. ; Sharpless K. B. 
Angew. Chem., Int. Ed. 
2002 , 41 , 2596 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4 . b Whiting M. ; Fokin V. V. 
Angew. Chem., Int. Ed. 
2006 , 45 , 3157 10.1002/anie.200503936 .
For selected examples, see:

a Chang S. ; Lee M. ; Jung D. Y. ; Yoo E. J. ; Cho S. H. ; Han S. K. 
Catalytic One-Pot
Synthesis of Cyclic
Amidines by Virtue of Tandem Reactions Involving Intramolecular Hydroamination
under Mild Conditions . J. Am. Chem. Soc. 
2006 , 128 , 12366 –12367 . 10.1021/ja064788i .16984157  b Yoo E. J. ; Chang S. 
A New Route to Indolines by the Cu-Catalyzed
Cyclization Reaction of 2-Ethynylanilines with Sulfonyl Azides . Org. Lett. 
2008 , 10 , 1163 –1166 . 10.1021/ol800049b .18288852  c Cui S.-L. ; Wang J. ; Wang Y. 
Facile Access to Pyrazolines
via Domino Reaction of the Huisgen Zwitterions with Aziridines . Org. Lett. 
2008 , 10 , 13 –16 . 10.1021/ol7022888 .18062691  d Bae I. ; Han H. ; Chang S. 
Highly Efficient One-Pot
Synthesis of N-Sulfonylamidines by Cu-Catalyzed Three-Component Coupling
of Sulfonyl Azide, Alkyne, and Amine . J. Am.
Chem. Soc. 
2005 , 127 , 2038 –2039 . 10.1021/ja0432968 .15713069  e Cho S. H. ; Yoo E. J. ; Bae I. ; Chang S. 
Copper-Catalyzed
Hydrative Amide Synthesis with Terminal Alkyne, Sulfonyl Azide, and
Water . J. Am. Chem. Soc. 
2005 , 127 , 16046 –16047 . 10.1021/ja056399e .16287290  f Cho S. H. ; Chang S. 
Rate-Accelerated Nonconventional Amide Synthesis in Water: A Practical
Catalytic Aldol-Surrogate Reaction . Angew. Chem.,
Int. Ed. 
2007 , 46 , 1897 –1900 . 10.1002/anie.200604358 . g Cho S. H. ; Chang S. 
Angew. Chem., Int. Ed. 
2008 , 47 , 2836 10.1002/anie.200705940 . h Yoo E.
J. ; Park S. H. ; Lee S. H. ; Chang S. 
A New Entry of Copper-Catalyzed Four-Component
Reaction: Facile Access to α-Aryl β-Hydroxy Imidates . Org. Lett. 
2009 , 11 , 1155 –1158 . 10.1021/ol900023t .19209900  i Husmann R. ; Na Y. S. ; Bolm C. ; Chang S. 
Copper-catalyzed
one-pot synthesis of α-functionalized imidates . Chem. Commun. 
2010 , 46 , 5494 10.1039/c0cc00941e . j Lu W. ; Song W. Z. ; Hong D. ; Lu P. ; Wang Y. 
Copper-Catalyzed One-Pot Synthesis of 2-Alkylidene-1,2,3,4- tetrahydropyrimidines . Adv. Synth. Catal. 
2009 , 351 , 1768 10.1002/adsc.200900260 . k Jin H. ; Xu X. ; Gao J. ; Zhong J. ; Wang Y. 
Copper-Catalyzed One-Pot Synthesis of Substituted Benzimidazoles . Adv. Synth. Catal. 
2010 , 352 , 347 10.1002/adsc.200900706 . l Song W. ; Lu W. ; Wang J. ; Lu P. ; Wang Y. 
A Facile Route to γ-Nitro Imidates via Four-Component Reaction
of Alkynes with Sulfonyl Azides, Alcohols, and Nitroolefins . J. Org. Chem. 
2010 , 75 , 3481 10.1021/jo100354h .20373817  m Cui S.-L. ; Wang J. ; Wang Y. 
Copper-Catalyzed Multicomponent
Reaction: Facile Access to Functionalized 5-Arylidene-2-imino-3-pyrrolines . Org. Lett. 
2007 , 9 , 5023 –5025 . 10.1021/ol702241e .17979278  n Wang J. ; Wang J. ; Zhu Y. ; Lu P. ; Wang Y. 
Copper-Cascade Catalysis: Synthesis of 3-Functionalized Indoles . Chem. Commun. 
2011 , 47 , 3275 –3277 . 10.1039/c0cc04922k . o Wang J. ; Lu P. ; Wang Y. 
Copper-catalyzed
multi-component synthesis of acrylamidines and benzoimidazoles . Org. Chem. Front. 
2015 , 2 , 1346 –1351 . 10.1039/C5QO00196J . p Xing Y. ; Cheng B. ; Wang J. ; Lu P. ; Wang Y. 
Copper-Catalyzed Three-Component Synthesis of 3-Aminopyrazoles
and 4-Iminopyrimidines via β-Alkynyl-N-sulfonyl Ketenimine Intermediates . Org. Lett. 
2014 , 16 , 4814 –4817 . 10.1021/ol502302w .25167465  q Sun L. ; Zhu Y. ; Lu P. ; Wang Y. 
Cu-Catalyzed
1,2-Dihydroisoquinolines Synthesis from o-Ethynyl Benzacetals and
Sulfonyl Azides . Org. Lett. 
2013 , 15 , 5894 –5897 . 10.1021/ol402996x .24191743  r Wang J. ; Wang J. ; Lu P. ; Wang Y. 
Copper-Catalyzed Cascade
Preparation of Dihydropyrimidin-4-ones from N-(Prop-2-yn-1-yl)amides
and Azides . J. Org. Chem. 
2013 , 78 , 8816 –8820 . 10.1021/jo401094j .23902364  s Jiang Z. ; Lu P. ; Wang Y. 
Three-Component Reaction of Propargyl Amines, Sulfonyl
Azides, and Alkynes: One-Pot Synthesis of Tetrasubstituted Imidazoles . Org. Lett. 
2012 , 14 , 6266 –6269 . 10.1021/ol303023y .23193963 
a Shang Y. ; He X. ; Hu J. ; Wu J. ; Zhang M. ; Yu S. ; Zhang Q. 
Copper-Catalyzed Efficient
Multicomponent Reaction: Synthesis of Benzoxazoline-Amidine Derivatives . Adv. Synth. Catal. 
2009 , 351 , 2709 10.1002/adsc.200900525 . b Cano I. ; Alvarez E. ; Nicasio M. C. ; Péerez P. J. 
Regioselective
Formation of 2,5-Disubstituted Oxazoles Via Copper(I)-Catalyzed Cycloaddition
of Acyl Azides and 1-Alkynes . J. Am. Chem. Soc. 
2011 , 133 , 191 10.1021/ja109732s .21171608  c Yao W. ; Pan L. ; Zhang Y. ; Wang G. ; Wang X. ; Ma C. 
Three-component
assembly and divergent ring-expansion cascades of functionalized 2-iminooxetanes . Angew. Chem., Int. Ed. 
2010 , 49 , 9210 10.1002/anie.201004685 . d Chen Z. ; Ye C. ; Gao L. ; Wu J. 
Diversity-oriented
approach to 1,2-dihydroisoquinolin-3(4H)-imines via
copper(I)-catalyzed reaction of (E)-2-ethynylphenylchalcone, sulfonyl
azide and amine . Chem. Commun. 
2011 , 47 , 5623 –5626 . 10.1039/c1cc11176k . e Shang Y. ; Ju K. ; He X. ; Hu J. ; Yu S. ; Zhang M. ; Liao K. ; Wang L. ; Zhang P. 
J. Org. Chem. 
2010 , 75 , 5743 10.1021/jo1010075 .20704448  f Chen Z. ; Zheng D. ; Wu J. 
A Facile Route to Polysubstituted
Indoles via Three-Component Reaction of 2-Ethynylaniline, Sulfonyl
Azide, and Nitroolefin . Org. Lett. 
2011 , 13 , 848 –851 . 10.1021/ol102775s .21299243  g Namitharana K. ; Pitchumani K. 
Copper(I)-catalyzed [3+2] cycloaddition/ring-opening
rearrangement/[4+2] cycloaddition/aromatization cascade. An unprecedented
chemo- and stereoselective three-component coupling of sulfonyl azide,
alkyne and N-arylidenepyridin-2-amine to pyrido[1,2-a]pyrimidin-4-imine . Adv. Synth. Catal. 
2013 , 355 , 93 10.1002/adsc.201200654 . h Yao B.-B. ; Shen C. ; Liang Z.-J. ; Zhang Y.-H. 
Copper-Catalyzed
Reaction of Ketenimine and in Situ Generated Immonium Ion: Access
to α,β-Unsaturated Amidines . J.
Org. Chem. 
2014 , 79 , 936 10.1021/jo402368x .24392993  i Li B.-S. ; Yang B.-M. ; Wang S.-H. ; Zhang Y.-Q. ; Cao X.-P. ; Tu Y.-Q. 
Copper(i)-catalyzed intramolecular
[2 + 2] cycloaddition of 1,6-enyne-derived ketenimine: an efficient
construction of strained and bridged 7-substituted-3-heterobicyclo[3.1.1]heptan-6-one . Chem. Sci. 
2012 , 3 , 1975 10.1039/c2sc20109g . j Cheng G. ; Cui X. 
Efficient Approach to 4-Sulfonamidoquinolines
via Copper(I)-Catalyzed Cascade Reaction of Sulfonyl Azides with Alkynyl
Imines . Org. Lett. 
2013 , 15 , 1480 10.1021/ol400219n .23521106  k Rajagopal B. ; Chen Y.-Y. ; Chen C.-C. ; Liu X.-Y. ; Wang H.-R. ; Lin P.-C. 
Cu(I)-Catalyzed
Synthesis of Dihydropyrimidin-4-ones toward the Preparation of β-
and β3-Amino Acid Analogues . J. Org. Chem. 
2014 , 79 , 1254 10.1021/jo402670d .24417351  l Ramanathan D. ; Pitchumani K. 
Copper(I)-Catalyzed One-Pot Synthesis of Highly Functionalized
Pyrrolidines from Sulfonyl Azides, Alkynes, and Dimethyl 2-(phenylamino)maleate . Eur. J. Org. Chem. 
2015 , 2015 , 463 10.1002/ejoc.201403285 .
a Cui S.-L. ; Lin X.-F. ; Wang Y.-G. 
Novel and
Efficient Synthesis of Iminocoumarins via Copper-Catalyzed Multicomponent
Reaction . Org. Lett. 
2006 , 8 , 4517 10.1021/ol061685w .16986939  b Shen Y. ; Cui S. ; Wang J. ; Chen X. ; Lu P. ; Wang Y.-G. 
Copper-Catalyzed
Three-Component Synthesis of 2-Iminodihydrocoumarins and 2-Iminocoumarins . Adv. Synth. Catal. 
2010 , 352 , 1139 10.1002/adsc.200900890 .
Yi F. ; Zhang S. ; Huang Y. ; Zhang L. ; Yi W. 
An Efficient
One-Pot Protocol for the Synthesis of Polysubstituted 4-Amino-iminocoumarins
and 4-Aminoquinolines by a Copper-Catalyzed Three-Component Reaction . Eur. J. Org. Chem. 
2017 , 102 –110 . 10.1002/ejoc.201601217 .
a Han Y. ; Li X. ; Sun Z. ; Zhu X. ; Li M. ; Song X. ; Liang Y.-M. 
Lewis acid-catalyzed
[4+2] annulation between propargylic alcohols with benzo[d]isoxazoles . Adv. Synth. Catal. 
2017 , 359 , 2735 –2740 . 10.1002/adsc.201700495 . b Lei X. ; Gao M. ; Tang Y. 
Rh(II)-Catalyzed Transannulation
of N-Sulfonyl-1,2,3-Triazoles with 2,1-Benzisoxazoles
or 1,2-Benzisoxazoles . Org. Lett. 
2016 , 18 , 4990 –4993 . 10.1021/acs.orglett.6b02454 .27672715 
a Kemp D. S. ; Casey M. L. 
Physical organic
chemistry of benzisoxazoles. II. Linearity of the Brønsted free
energy relation for the base-catalyzed decomposition of benzisoxazoles . J. Am. Chem. Soc. 
1973 , 95 , 6670 –6680 . 10.1021/ja00801a024 . b Casey M. L. ; Kemp D. S. ; Paul K. G. ; Cox D. D. 
Physical organic chemistry of benzisoxazoles. I. Mechanism
of the base-catalyzed decomposition of benzisoxazoles . J. Org. Chem. 
1973 , 38 , 2294 –2301 . 10.1021/jo00953a006 .
For a radical ring-opening
of benzoisoxazole: Nunes C. M. ; Pinto S. M. V. ; Reva I. ; Fausto R. 
Photochemistry of 3-amino-1,2-benzisoxazole:
unexpected photoisomerization of an amino-spiro-2H-azirine to a 1H-diazirine . Tetrahedron Lett. 
2016 , 57 , 5038 –5041 . 10.1016/j.tetlet.2016.09.098 .
a Zhao Y. ; Beuchat C. ; Domoto Y. ; Gajewy J. ; Wilson A. ; Mareda J. ; Sakai N. ; Matile S. 
Anion-π Catalysis . J. Am.
Chem. Soc. 
2014 , 136 , 2101 –2111 . 10.1021/ja412290r .24456523  b Röthlisberger D. ; Khersonsky O. ; Wollacott A. ; Jiang L. ; DeChancie J. ; Betker J. ; Gallaher J. ; Althoff E. ; Zanghellini A. ; Dym O. ; Albeck S. ; Houk K. N. ; Tawfik D. S. ; Baker D. 
Kemp elimination
catalysts by computational enzyme design . Nature 
2008 , 453 , 190 –195 . 10.1038/nature06879 .18354394  c Hu Y. ; Houk K. N. ; Kikuchi K. ; Hotta K. ; Hilvert D. 
Nonspecific
medium effects versus specific group positioning in the antibody and
albumin catalysis of the base-promoted ring-opening reactions of benzisoxazoles . J. Am. Chem. Soc. 
2004 , 126 , 8197 –8205 . 10.1021/ja0490727 .15225061  d Kennan A. J. ; Whitlock H. W. 
Host-Catalyzed Isoxazole
Ring Opening: A Rationally Designed Artificial Enzyme . J. Am. Chem. Soc. 
1996 , 118 , 3027 –3028 . 10.1021/ja953887l .
Yoo E. J. ; Ahlquist M. ; Kim S. K. ; Bae I. ; Fokin V. V. ; Sharpless K. B. ; Chang S. 
Copper-Catalyzed Synthesis
of N-Sulfonyl-1,2,3-triazoles: Controlling Selectivity . Angew. Chem., Int. Ed. 
2007 , 46 , 1730 –1733 . 10.1002/anie.200604241 .
CCDC
1586533 (4d) contain the supplementary crystallographic
data for this paper.
Bargagna A. ; Longobardi M. ; Mariani E. ; Schenone P. ; Russo S. ; Vitagliano S. ; De Novellis V. ; Marmo E. 
N,N-Disubstituted 4-amino-(6-methoxy)-3-phenyl-2H-naphtho[1,2-b]pyran-2-ones with antiarrhythmic,
platelet-antiaggregating and local-anesthetic activities . Farmaco, Ed. Sci. 
1988 , 43 , 857 –877 .

